About Glenmark Life Sciences
Glenmark Life Sciences Ltd., a subsidiary of Glenmark Pharmaceuticals Ltd., is a leading developer and manufacturer of select high-value, non-commoditized active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. It also manufactures and sells APIs for gastro-intestinal disorders, anti-infectives, and other therapeutic areas.;
Glenmark Life Sciences Ltd.
Glenmark Life Sciences IPO review - Glenmark Life Sciences IPO details, business, financials